Mizoribine
From Self-sufficiency
Revision as of 16:42, 29 July 2010 by PotatoBot (Talk) (Stub sorting and placement of stub template(s))
| File:Mizoribine.png | |
| Systematic (IUPAC) name | |
|---|---|
|
5-hydroxy-1-β-D-ribofuranosyl-1H-imidazole-4-carboxamide | |
| Clinical data | |
| Routes of administration | Oral |
| Legal status | |
| Legal status |
|
| Identifiers | |
| CAS Number | 50924-49-7 |
| ATC code | none |
| PubChem | CID 104762 |
| Synonyms | 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-hydroxyimidazole-4-carboxamide |
| Chemical data | |
| Formula | C9H13N3O6 |
| Molar mass | 259.21 g/mol[[Script error: No such module "String".]] |
| Script error: No such module "collapsible list". | |
Mizoribine (INN, trade name Bredinin) is an immunosuppresive drug. The compound was first observed in Tokyo, Japan, in 1971.[1] It is a natural product, first isolated from the mould Eupenicillium brefeldianum.
References
Cite error: Invalid <references> tag;
parameter "group" is allowed only.
<references />, or <references group="..." />
| 40px | This antineoplastic or immunomodulatory drug article is a stub. You can help ssf by expanding it. |
- ↑ Hiroaki Ishikawa (1999). "Mizoribine and Mycophenolate Mofetil". Current Medicinal Chemistry. Bentham Science: 575–597.
Categories:
- Pages with script errors
- Pages with broken file links
- Drugs with non-standard legal status
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs not assigned an ATC code
- Articles containing unverified chemical infoboxes
- 2Fix
- Immunosuppressants
- Antineoplastic and immunomodulating drug stubs
